A Prospective, Singal-arm Clinical Study of Recombinant Human Endostatin (ENDOSTAR) Combined With Carboplatin and Vincristine in the Treatment of Low-grade Gliomas in Children
Latest Information Update: 26 Jul 2023
At a glance
- Drugs Carboplatin (Primary) ; Endostatin (Primary) ; Vincristine (Primary)
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 20 Jul 2023 Status changed from recruiting to completed.
- 24 Dec 2020 New trial record
- 09 Dec 2020 Planned initiation date changed from 1 Dec 2020 to 20 Dec 2020.